A preliminary investigation of the association between serum uric acid and impaired renal function.

作者: Yi-Cheng Chen , Chien-Tien Su , Sen-Te Wang , Hsin-Dai Lee , Shiyng-Yu Lin

DOI:

关键词:

摘要: BACKGROUND Hemodialysis for end-stage renal disease (ESRD) incurs huge medical costs in Taiwan. We set out to determine if it is possible help control chronic with early treatment of hyperuricemia. METHODS Data from Taipei Medical University Hospital (TMUH) health center January 2004 December 2006 were analyzed correlate function and blood uric acid concentration. Patients divided into 5 groups according their serum concentration ( 10 mg/dl). According our laboratory data, elevated creatinine levels (> 1.3 mg/dL) indicated impaired function. RESULTS In total, there 5722 patients, including 2816 (49.2%) men 2906 (50.8%) women, a median age 67. Impaired was noted 307 (5.4%) cases. Serum significantly correlated urea nitrogen creatinine. Groups higher level had an increased risk CONCLUSION Our purpose this preliminary observation try define starting point the acid, order avoid development found that < 6 mg/dl seemed be associated less impairment.

参考文章(17)
P Chou, K C Lin, H Y Lin, Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. The Journal of Rheumatology. ,vol. 27, pp. 1045- 1050 ,(2000)
Coralie Bingham, Sian Ellard, William G. van't Hoff, H. Anne Simmonds, Anthony M. Marinaki, Michael K. Badman, Peter H. Winocour, Amanda Stride, Christopher R. Lockwood, Anthony J. Nicholls, Katharine R. Owen, Ghislaine Spyer, Ewan R. Pearson, Andrew T. Hattersley, Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1β gene mutation Kidney International. ,vol. 63, pp. 1645- 1651 ,(2003) , 10.1046/J.1523-1755.2003.00903.X
W.Jeffrey Fessel, Renal outcomes of gout and hyperuricemia The American Journal of Medicine. ,vol. 67, pp. 74- 82 ,(1979) , 10.1016/0002-9343(79)90076-7
Peter Igarashi, Xinli Shao, Brian T. Mcnally, Thomas Hiesberger, Roles of HNF-1β in kidney development and congenital cystic diseases Kidney International. ,vol. 68, pp. 1944- 1947 ,(2005) , 10.1111/J.1523-1755.2005.00625.X
Arthur P. Hall, Peter E. Barry, Thomas R. Dawber, Patricia M. McNamara, Epidemiology of gout and hyperuricemia The American Journal of Medicine. ,vol. 42, pp. 27- 37 ,(1967) , 10.1016/0002-9343(67)90004-6
Chiho Iseki, Shuichi Takishita, Yoshiharu Ikemiya, Kunitoshi Iseki, Kozen Kinjo, Taku Inoue, Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. American Journal of Kidney Diseases. ,vol. 44, pp. 642- 650 ,(2004) , 10.1053/J.AJKD.2004.06.006
Edward W. Campion, Robert J. Glynn, Lorraine O. Delabry, Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. The American Journal of Medicine. ,vol. 82, pp. 421- 426 ,(1987) , 10.1016/0002-9343(87)90441-4
Herbert G Langford, M Donald Blaufox, Nemat O Borhani, J David Curb, Agostino Molteni, Kenneth A Schneider, Sara Pressel, Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program Archives of Internal Medicine. ,vol. 147, pp. 645- 649 ,(1987) , 10.1001/ARCHINTE.147.4.645
Laura G. Sanchez-Lozada, Edilia Tapia, Jose Santamaria, Carmen Avila-Casado, Virgilia Soto, Tomas Nepomuceno, Bernardo Rodriguez-Iturbe, Richard J. Johnson, Jaime Herrera-Acosta, Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney International. ,vol. 67, pp. 237- 247 ,(2005) , 10.1111/J.1523-1755.2005.00074.X